Back to DSGN
D. E. Shaw & Co., Inc. DSGN Position History
Design Therapeutics, Inc. • Healthcare
Quarters held
23
Latest value
$133K
Q3 2026
Peak value
$4.7M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $770K |
| Q1 2024 | $1.7M |
| Q1 2024 | $75K |
| Q2 2024 | $1.6M |
| Q2 2024 | $157K |
| Q3 2024 | $2.8M |
| Q3 2024 | $367K |
| Q4 2024 | $2.7M |
| Q4 2024 | $472K |
| Q1 2025 | $1.3M |
| Q1 2025 | $267K |
| Q2 2025 | $1.1M |
| Q2 2025 | $214K |
| Q3 2025 | $2.5M |
| Q3 2025 | $340K |
| Q4 2025 | $3.9M |
| Q4 2025 | $200K |
| Q1 2026 | $4.7M |
| Q1 2026 | $347K |
| Q2 2026 | $2.7M |
| Q2 2026 | $159K |
| Q3 2026 | $2.2M |
| Q3 2026 | $133K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $133K | 10.6K | — | — |
| Q3 2026 | $2.2M | 175.5K | — | — |
| Q2 2026 | $159K | 11.0K | — | — |
| Q2 2026 | $2.7M | 184.6K | — | — |
| Q1 2026 | $347K | 32.6K | — | — |
| Q1 2026 | $4.7M | 437.7K | — | — |
| Q4 2025 | $200K | 21.3K | — | — |
| Q4 2025 | $3.9M | 417.6K | — | — |
| Q3 2025 | $340K | 45.2K | — | — |
| Q3 2025 | $2.5M | 328.1K | — | — |
| Q2 2025 | $214K | 63.4K | — | — |
| Q2 2025 | $1.1M | 327.2K | — | — |
| Q1 2025 | $267K | 69.3K | — | — |
| Q1 2025 | $1.3M | 326.0K | — | — |
| Q4 2024 | $472K | 76.4K | — | — |
| Q4 2024 | $2.7M | 435.9K | — | — |
| Q3 2024 | $367K | 68.2K | — | — |
| Q3 2024 | $2.8M | 514.7K | — | — |
| Q2 2024 | $157K | 46.9K | — | — |
| Q2 2024 | $1.6M | 488.9K | — | — |
| Q1 2024 | $75K | 18.7K | — | — |
| Q1 2024 | $1.7M | 427.5K | — | — |
| Q4 2023 | $770K | 290.6K | — | — |
Other funds holding DSGN
$111M
$96.4M
$81.6M
$71.9M